Furthermore, there is evidence that the nonselective nonsteroidal anti-inflammatory drug aspirin is efficacious for the prevention of hormone receptor-positive (ER-positive and progesterone receptor-positive) breast cancer but not hormone receptor-negative breast cancer [14]. The gene discussed is NR4A1; the disease is breast cancer.